BamSEC and AlphaSense Join Forces
Learn More

Castle Biosciences Inc.

NASDAQ: CSTL    
Share price (11/21/24): $28.88    
Market cap (11/21/24): $809 million
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.8
from S-3 18 pages Castle Biosciences, Inc. and , as Warrant Agent Form of Debt Securities Warrant Agreement Dated as of Castle Biosciences, Inc. Form of Debt Securities Warrant Agreement
12/34/56
EX-4.7
from S-3 20 pages Castle Biosciences, Inc. and , as Warrant Agent Form of Preferred Stock Warrant Agreement Dated as of Castle Biosciences, Inc. Form of Preferred Stock Warrant Agreement Article 1 Issuance of Warrants and Execution and Delivery of Warrant Certificates
12/34/56
EX-4.6
from S-3 20 pages Castle Biosciences, Inc. and , as Warrant Agent Form of Common Stock Warrant Agreement Dated as of 1 Castle Biosciences, Inc. Form of Common Stock Warrant Agreement Article 1 Issuance of Warrants and Execution and Delivery of Warrant Certificates
12/34/56
EX-4.3
from S-3 55 pages Castle Biosciences, Inc., Issuer and [Trustee], Trustee Indenture Dated as of [•], 20__ Debt Securities
12/34/56
EX-4.10
from S-3ASR 16 pages Castle Biosciences, Inc. and , as Warrant Agent Form of Debt Securities Warrant Agreement Dated as of [ ], 20 Castle Biosciences, Inc. Form of Debt Securities Warrant Agreement
12/34/56
EX-4.9
from S-3ASR 17 pages Castle Biosciences, Inc. and , as Warrant Agent Form of Preferred Stock Warrant Agreement Dated as of [ ], 20 Castle Biosciences, Inc. Form of Preferred Stock Warrant Agreement
12/34/56
EX-4.8
from S-3ASR 17 pages Castle Bioscences, Inc. and , as Warrant Agent Form of Common Stock Warrant Agreement Dated as of [ ], 20 Castle Biosciences, Inc. Form of Common Stock Warrant Agreement
12/34/56
EX-4.5
from S-3ASR 54 pages Castle Biosciences, Inc., Issuer and [Trustee], Trustee Indenture Dated as of [•], 20__ Debt Securities
12/34/56
EX-4.1
from 10-K 3 pages Description of Common Stock
12/34/56
EX-4.9
from S-1/A 10 pages Warrant to Purchase Shares of Common Stock of Castle Biosciences, Inc
12/34/56
EX-4.2
from S-1/A 41 pages Castle Biosciences, Inc. Sixth Amended and Restated Investors’ Rights Agreement July 12, 2019
12/34/56
EX-4.1
from S-1/A 2 pages Indenture or similar
12/34/56
EX-4.8
from S-1 8 pages Warrant to Purchase Shares of Series F Preferred Stock of Castle Biosciences, Inc
12/34/56
EX-4.7
from S-1 11 pages Warrant to Purchase Stock
12/34/56
EX-4.6
from S-1 12 pages Warrant to Purchase Stock
12/34/56
EX-4.5
from S-1 12 pages Warrant to Purchase Stock
12/34/56
EX-4.4
from S-1 13 pages This Warrant and the Shares Issuable Hereunder Have Not Been Registered Under the Securities Act of 1933, as Amended (The “Act”), or the Securities Laws of Any State And, Except as Set Forth in Sections 5.3 and 5.4 Below, May Not Be Offered, Sold, Pledged or Otherwise Transferred Unless and Until Registered Under Said Act and Applicable State Securities Laws Or, in the Opinion of Legal Counsel in Form and Substance Satisfactory to the Company, Such Offer, Sale, Pledge or Other Transfer Is Exempt From Such Registration
12/34/56
EX-4.3
from S-1 7 pages Stock Purchase Warrant to Purchase Shares of Series E‑1 Preferred Stock of Castle Biosciences, Inc
12/34/56
EX-4.2
from S-1 122 pages Castle Biosciences, Inc. Fifth Amended and Restated Investors’ Rights Agreement July 15, 2015
12/34/56
EX-4.8
from DRS 8 pages Warrant to Purchase Shares of Series F Preferred Stock of Castle Biosciences, Inc
12/34/56